By Professor Ric Day

Journal articles

Carey DL; Day RO; Bowden FJ, 1996, 'Managing HIV, Quick reference:drug interactions. Common drug interactions in HIV medicine', Medical Journal of Australia, 164, pp. 605 - 606

Mcmanus PA; Primrose JG; Henry D; Birkett DJ; Lindner J; Day RO, 1996, 'Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994, A report from the Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory', Medical Journal of Australia, 164, pp. 589 - 592

Graham GG; Day RO; Wong H; Mclachlan AJ; Bergendal L; Miners JO; Birkett DJ, 1996, 'Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects', British Journal of Clinical Pharmacology, pp. 299 - 304

Johnson AG; Nguyen TM; Owe-Young R; Williamson DJ; Day RO, 1996, 'Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-I', Journal of Hypertension, 10, pp. 257 - 261

Day RO; Francis H; Vial J; Geisslinger G; Williams KM, 1995, 'Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations', Journal of Rheumatology, 22, pp. 2295 - 2303

BOERS M; BROOKS P; TUGWELL P; BAKER P; BOMBARDIER C; DAY R; DRUMMOND M; VANDERLINDEN S; OBRIEN B; SILMAN A; STRAND V; WELLS G, 1995, 'OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - ACKNOWLEDGMENTS', JOURNAL OF RHEUMATOLOGY, 22, pp. 1433 - 1433, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RG24600046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Handel ML; Watts CKW; DeFazio A; Day RO; Sutherland RL, 1995, 'Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos', Proceedings of the National Academy of Sciences of the United States of America, 92, pp. 4497 - 4501, http://dx.doi.org/10.1073/pnas.92.10.4497

BROOKS PM; DAY RO, 1995, 'TOXICITY OF ANTIRHEUMATIC DRUGS', JOURNAL OF RHEUMATOLOGY, 22, pp. 998 - 999

JOHNSON AG; NGUYEN TV; DAY RO, 1995, 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND HIGH BLOOD-PRESSURE - RESPONSE', ANNALS OF INTERNAL MEDICINE, 122, pp. 397 - 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00028

Conaghan PG; Quinn DI; Brooks PM; Day RO, 1995, 'Hazards of low dose methotrexate', Australian and New Zealand Journal of Medicine, 25, pp. 670 - 673, http://dx.doi.org/10.1111/j.1445-5994.1995.tb02851.x

Johnson AG; Quinn DI; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158, http://dx.doi.org/10.5694/j.1326-5377.1995.tb127972.x

Radack K; Johnson AG; Nguyen TV; Day RO, 1995, 'Nonsteroidal anti-inflammatory drugs and high blood pressure [8]', Annals of Internal Medicine, 122, pp. 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00027

Brooks PM; Day R, 1995, 'Treatment issues', Bailliere S Clinical Rheumatology, 9, pp. 231 - 245, http://dx.doi.org/10.1016/S0950-3579(05)80158-X

Brooks PM; Day RO, 1995, 'Workshop report - Part 1: Toxicity of antirheumatic drugs', Journal of Rheumatology, 22, pp. 998 - 999

Day RO; Quinn DE; Conaghan PG; Tett S, 1995, 'Adverse drug reactions and their measurement in the rheumatic diseases', Journal of Rheumatology, pp. 983 - 988

Quinn DE; Day RO, 1995, 'Clinically Important Drug Interactions.', Drug Safety, 12, pp. 393 - 452

Quinn DE; Day RO, 1995, 'Drug interactions of clinical importance: an updated guide', Drug Safety, 12, pp. 393 - 452

Johnson AG; Quinn DE; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158

Day RO; Francis H; Vial JH; Geisslinger G; Williams KM, 1995, 'Pharmacokinetics and pharmacodynamics of naproxen in synovial fluid and plasma', Journal of Rheumatology, pp. 2295 - 2303

Day RO; Geisslinger G; Paull P; Williams KM, 1995, 'The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers', International journal of clinical pharmacology, pp. 308 - 310, https://www.ncbi.nlm.nih.gov/pubmed/7655772

Brooks PM; Day RO, 1995, 'Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders.', J Rheumatol, 22, pp. 998 - 999, https://www.ncbi.nlm.nih.gov/pubmed/8587098

Brooks PM; Day R, 1995, 'Tropical rheumatology. Treatment issues.', Baillieres Clin Rheumatol, 9, pp. 231 - 245, http://dx.doi.org/10.1016/s0950-3579(05)80158-x

Johnson AG; Nguyen TV; Day RO, 1994, 'Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis', Annals of Internal Medicine, 121, pp. 289 - 300, http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00011

Parnham MJ; Day RO; van den Berg WB, 1994, 'Inflammation '93', Agents and Actions, 41, pp. C145 - C149, http://dx.doi.org/10.1007/BF01987616

Johnson AG; Nuygen TV; Day RO, 1994, 'Evaluation of the accuracy and reproducibility of ambulatory blood pressure monitoring in the very elderly using the Takeda TM-2420', Journal of Human Hypertension, 8, pp. 433 - 439

LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1994, 'EFFECT OF HCL CONCENTRATION ON GASTRIC BLOOD-FLOW IN ACUTE ASPIRIN-INDUCED GASTRIC-ULCERS IN THE CAT', GASTROENTEROLOGY, 106, pp. A123 - A123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NH90900484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mclachlan AJ; Tett SE; Cutler DJ; Day RO, 1994, 'Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis', Rheumatology, 33, pp. 235 - 239, http://dx.doi.org/10.1093/rheumatology/33.3.235

Day R; Quinn D, 1994, 'Adverse Interaction Between Warfarin and Indomethacin', Drug Safety, 11, pp. 213 - 214, http://dx.doi.org/10.2165/00002018-199411030-00006

Day R; Wodak A; Chesher G, 1994, 'Cannabis and suicide [3]', Medical Journal of Australia, 160, pp. 731, http://dx.doi.org/10.5694/j.1326-5377.1994.tb125924.x

Walker J; Nguyen T; Day R, 1994, 'Clinical response to non‐steroidal anti‐inflammatory drugs in urate‐ crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability.', British Journal of Clinical Pharmacology, 38, pp. 341 - 347, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04364.x

McLachlan AJ; Tett SE; Cutler DJ; Day RO, 1994, 'Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate', Chirality, 6, pp. 360 - 364, http://dx.doi.org/10.1002/chir.530060421

Day R, 1994, 'Meeting report: Asian conference on clinical pharmacology and therapeutics', British Journal of Clinical Pharmacology, 38, pp. 197 - 198

Day R; Geisslinger G; Paull P; Williams K, 1994, 'Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.', British Journal of Clinical Pharmacology, 37, pp. 79 - 81, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04244.x

Day RO; Birkett DJ; Hicks M; Miners JO; Graham GG; Brooks PM, 1994, 'New Uses for Allopurinol', Drugs, 48, pp. 339 - 344, http://dx.doi.org/10.2165/00003495-199448030-00002

Johnson AG; Seidemann P; Day RO, 1994, 'NSAID-related adverse drug interactions with clinical relevance. An update', International Journal of Clinical Pharmacology and Therapeutics, 32, pp. 509 - 532

Tett SE; McLachlan AJ; Cutler DJ; Day RO, 1994, 'Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate', Chirality, 6, pp. 355 - 359, http://dx.doi.org/10.1002/chir.530060420

Conaghan PG; Day RO, 1994, 'Risks and Benefits of Drugs Used in the Management and Prevention of Gout', Drug Safety, 11, pp. 252 - 258, http://dx.doi.org/10.2165/00002018-199411040-00004

Seideman P; Lohrer F; Graham G; Duncan M; Williams K; Day R, 1994, 'The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.', British Journal of Clinical Pharmacology, 38, pp. 221 - 227, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04345.x

Tett SE; Day RO; Cutler DJ, 1993, 'Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis - A cross sectional study', Journal of Rheumatology, 20, pp. 1874 - 1879

Day RO; Wacher T; Cairns D; Conners G; Mcgrath M, 1993, 'Nailfold capillary circulation in osteoarthritis', Rheumatology, 32, pp. 1062 - 1065, http://dx.doi.org/10.1093/rheumatology/32.12.1062

McLachlan A; Tett S; Day R; Cutler D, 1993, 'Interpretation of chloroquine pharmacokinetic data', European Journal of Clinical Pharmacology, 44, pp. 407 - 408, http://dx.doi.org/10.1007/BF00316484

Hicks M; Wong LS; Day RO, 1993, 'Suitability of reverse-phase columns from different sources for separation of uric acid from its oxidation products', Analytical Biochemistry, 210, pp. 428 - 430, http://dx.doi.org/10.1006/abio.1993.1221

McLACHLAN AJ; TETT SE; CUTLER DJ; DAY RO, 1993, 'Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques', British Journal of Clinical Pharmacology, 36, pp. 405 - 411, http://dx.doi.org/10.1111/j.1365-2125.1993.tb00388.x

Johnson AG; Seideman P; Day RO, 1993, 'Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Recognition, Management and Avoidance', Drug Safety, 8, pp. 99 - 127, http://dx.doi.org/10.2165/00002018-199308020-00002

Diamond HS; Fitzgerald LL; Day R, 1993, 'An analysis of the cost and revenue of an expanded medical residency', Journal of General Internal Medicine, 8, pp. 614 - 618, http://dx.doi.org/10.1007/BF02599717

WALKER JS; ARROYO JF; NGUYEN T; DAY RO, 1993, 'Analgesic efficacy of non‐steroidal anti‐inflammatory drugs in experimental pain in humans', British Journal of Clinical Pharmacology, 36, pp. 417 - 425, http://dx.doi.org/10.1111/j.1365-2125.1993.tb00390.x

Williams KM; Day RO; Breit SN, 1993, 'Biochemical actions and clinical pharmacology of anti-inflammatory drugs', Advances in Drug Research, 24, pp. 121 - 198

Tett SE; Day RO; Lauchlan R, 1993, 'Clinical pharmacy and clinical pharmacology', Australian Journal of Hospital Pharmacy, 23, pp. 207 - 210

Handel ML; Sivertsen S; Watts CKW; Day RO; Sutherland RL, 1993, 'Comparative effects of gold on the interactions of transcription factors with DNA', Agents and Actions, 44, pp. 219 - 223

McLachlan A; Tett S; Cutler D; Day R, 1993, 'Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.', British Journal of Clinical Pharmacology, 36, pp. 78 - 81, http://dx.doi.org/10.1111/j.1365-2125.1993.tb05897.x

Back to profile page